EN DE
STOCK COMPARISON

Abbott Laboratories vs Vycor Medical: Fair Value & Quality

Both stocks run through our valuation models. Here is how Abbott Laboratories (ABT) and Vycor Medical (VYCO) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Abbott Laboratories trades at $103 versus a fair value of $74.79 (-28%), while Vycor Medical trades at $0.07 versus $0.03 (-57%).
Abbott Laboratories
ABT · USD · Health Care
-28%
upside to fair value
overvalued
Price$103
Fair Value$74.79
Quality66/100
Vycor Medical
VYCO · USD · Health Care
-57%
upside to fair value
overvalued
Price$0.07
Fair Value$0.03
Quality49/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Abbott LaboratoriesVycor Medical
Valuation
28.5×P/E (TTM)n/a
4.01×P/S (TTM)1.19×
3.47×P/BNegative equity
15.5×EV/EBITDA14.7×
1.47×PEGn/a
−27.7%Fair value upside−57.0%
2.4%Dividend yieldn/a
$2.48Dividend per sharen/a
Profitability
13%Operating margin10%
1.19×EBIT margin trend (5Y)n/a
12%Return on equityNegative equity
6%Return on assets6%
Growth
8%Revenue growth (YoY)5%
0.5%Avg. growth/yr (3Y)15.1%
5.1%Avg. growth/yr (5Y)10.3%
+10.6%Value creation/yrn/a
Balance & size
23.6×Interest coverage (EBIT/interest)0.3×
0.19×Debt / equityNegative equity
$181BMarket cap$2M
healthyGrowth qualityexpensive

Even match: 4 to 4 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Abbott Laboratoriesof which business quality 66 · market factors 48 Vycor Medicalof which business quality 44 · market factors 25
ProfitabilityMargins and returns on capital today
50
50
Quality GrowthAre margins and returns improving?
47
64
CashflowEarnings quality: real cash, not paper profit
71
9
Fin. StrengthBalance sheet, leverage, solvency risk
80
9
InvestmentDisciplined investing over empire-building
65
100
Low VolatilityCalm price path (market factor)
84
50
MomentumPrice trend over the last 3–12 months (market factor)
39
19
52W MomentumDistance to the 52-week high (market factor)
23
6
Net IssuanceShare count: buybacks or dilution?
83
77

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyAbbott LaboratoriesPrice $103Vycor MedicalPrice $0.07
DCF Models-28%below the price$74.80n/a
Earnings-Based-72%below the price$29.42-85%below the price$0.01
Dividend Discount-62%below the price$39.73n/a
Multiples-32%below the price$70.72-70%below the price$0.02
Asset-Based-81%below the price$20.05n/a
Growth DCF-34%below the price$68.58n/a
Economic Profit-64%below the price$37.49-85%below the price$0.01
Growth Earnings-32%below the price$70.25n/a
Minimum-81%below the price$20.05-85%below the price$0.01
Maximum-28%below the price$74.80-70%below the price$0.02
Median-48%below the price$54.15-85%below the price$0.01
Geometric mean-55%below the price$46.64-81%below the price$0.01

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

Vycor Medical: 5 of 5 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Abbott Laboratories
Price $103
Fair Value $74.79
Bear $52.12Bull $94.43

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Abbott Laboratories · Health Care

Quality score66 · Top 25%
Fair value upside-28% · below median

Vycor Medical · Health Care

Quality score49 · below median
Fair value upside-57% · below median

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Abbott Laboratories trades at $103 versus a fair value of $74.79 (-28%), while Vycor Medical trades at $0.07 versus $0.03 (-57%).

Abbott Laboratories has the higher quality score (66/100).

Open Abbott Laboratories live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.